Protective effect of the SOD/catalase mimetic MnTMPyP on inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuronal-glial cultures

Journal of Neuroimmunology

Volumn 147, Issue 1-2, 2004, Pages 68-72

  Wang, Tongguang ^a   Liu, Bin ^a   Qin, Liya ^a   Wilson, Belinda ^a   Hong, Jau Shong ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Dopamine; Lipopolysaccharide; Microglia; MnTMPyP; Prostaglandin E2; Reactive oxygen species

Indexed keywords

CATALASE; DOPAMINE; LIPOPOLYSACCHARIDE; METALLOPORPHYRIN; NEUROPROTECTIVE AGENT; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE; SUPEROXIDE DISMUTASE; TETRAKIS(1 METHYL 4 PYRIDYL)PORPHYRIN MANGANESE; TETRAKIS(N METHYL 4 PYRIDINIUMYL)PORPHINE MANGANESE(III) COMPLEX; TETRAKIS(N-METHYL-4-PYRIDINIUMYL)PORPHINE MANGANESE(III) COMPLEX; TRITIUM; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL; ANIMAL CELL; ATTENUATION; CELL CULTURE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOLOGY; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; DRUG MECHANISM; GLIA; GLIA CELL; IATROGENIC DISEASE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MESENCEPHALON; METABOLISM; MOLECULAR MIMICRY; NERVE CELL; NERVE CELL CULTURE; NERVE CELL DEGENERATION; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN;

EID: 1342316811     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.10.040     Document Type: Conference Paper

References (24)

1. Aloisi F. The role of microglia and astrocytes in CNS immune surveillance and immunopathology. Adv. Exp. Med. Biol. 468:1999;123-133.
2. Banati R.B., Daniel S.E., Blunt S.B. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov. Disord. 13:1998;221-227.
3. Berridge M.V., Tan A.S. Trans-plasma membrane electron transport: a cellular assay for NADH- and NADPH-oxidase based on extracellular, superoxide-mediated reduction of the sulfonated terazolium salt WST-1. Protoplasm. 205:1998;74-82.
4. Bronstein D.M., Perez-Otano I., Sun V., Mullis-Sawin S.B., Chan J., Wu G.C., Hudson P.M., Kong L.Y., Hong J.S., McMillian M.K. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res. 704:1995;112-116.
5. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia. 7:1993;75-83.
6. Farber J.L. Mechanisms of cell injury by activated oxygen species. Environ. Health Perspect. 102(suppl. 10):1994;17-24.
7. Gao H.M., Jiang J., Wilson B., Zhang W., Hong J.S., Liu B. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J. Neurochem. 81:2002;1285-1297.
8. Gonzalez-Scarano F., Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22:1999;219-240.
9. Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J.D., Wenk G.L. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res. 780:1998;294-303.
10. Hirsch E.C. Glial cells and Parkinson's disease. J. Neurol. 247:2000;II58-II62.
11. Hsu H.Y., Wen M.H. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J. Biol. Chem. 277:2002;22131-22139.
12. Kang J., Park E.J., Jou I., Kim J.H., Joe E.H. Reactive oxygen species mediate Aβ(25-35)-induced activation of BV-2 microglia. Neuroreport. 12:2001;1449-1452.
13. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:1996;312-318.
14. Liu B., Hong J.S. Role of microglia in inflammation-mediated neurodegeneration. J. Pharmacol. Exp. Ther. 304:2003;1-7.
15. Liu B., Du L., Hong J.S. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide. J. Pharmacol. Exp. Ther. 293:2000;607-617.
16. Liu B., Wang K., Gao H.M., Mandavilli B., Wang J.Y., Hong J.S. Molecular consequences of activated microglia in the brain: overactivation induces apoptosis. J. Neurochem. 77:2001;182-189.
17. Liu B., Gao H.M., Wang J.-Y., Jeohn G.-H., Coper C.L., Hong J.S. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann. N.Y. Acad. Sci. 962:2002;700-715.
18. McGeer P.L., Itagaki S., Boyes B., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 38:1988;1285-1291.
19. Minghetti L., Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 54:1998;99-125.
20. Qin L., Liu Y., Cooper C., Liu B., Wilson B., Hong J.S. Microglia enhance β-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J. Neurochem. 83:2002;973-983.
21. Raine C.S. Multiple sclerosis: immune system molecule expression in the central nervous system. J. Neuropathol. Exp. Neurol. 53:1994;328-337.
22. Rogers J., Shen Y. A perspective on inflammation in Alzheimer's disease. Ann. N.Y. Acad. Sci. 924:2000;132-135.
23. Sanlioglu S., Williams C.M., Samavati L., Butler N.S., Wang G., McCray P.B., Ritchie T.C., Hunninghake G.W., Zandi E., Engelhardt J.F. Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-α secretion through IKK regulation of NF-κB. J. Biol. Chem. 276:2001;30188-30198.
24. Streit W.J. Microglia response to brain injury: a brief synopsis. Toxicol. Pathol. 28:2000;28-30.